VALIDATION OF THE NCCN-IPI FOR THE PROGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN A SERIES OF 1848 PATIENTS. THE INCLUSION OF B2 MICROGLOBULIN (B2MCG) RESULTS IN AN INDEX WITH BETTER DISCRIMINATION, THE GELTAMO-IPI

HAEMATOLOGICA(2016)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要